Your browser doesn't support javascript.
loading
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.
Diacon, Andreas; Miyahara, Sachiko; Dawson, Rodney; Sun, Xin; Hogg, Evelyn; Donahue, Kathleen; Urbanowski, Michael; De Jager, Veronique; Fletcher, Courtney V; Hafner, Richard; Swindells, Susan; Bishai, William.
Afiliación
  • Diacon A; Division of Physiology, Department of Medical Biochemistry, Stellenbosch University, Cape Town, South Africa.
  • Miyahara S; Task Applied Science, Tuberculosis Clinical Research Centre, Bellville, Cape Town, South Africa.
  • Dawson R; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Sun X; Task Applied Science, Tuberculosis Clinical Research Centre, Bellville, Cape Town, South Africa.
  • Hogg E; University of Cape Town Lung Institute and Division of Pulmonology, Department of Medicine, Groote Schuur Hospital, Cape Town, South Africa.
  • Donahue K; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Urbanowski M; Social & Scientific Systems, Inc., Silver Spring, Maryland, USA.
  • De Jager V; Frontier Science & Technology Research Foundation Inc., Amherst, New York, USA.
  • Fletcher CV; Center for TB Research, Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Hafner R; Task Applied Science, Tuberculosis Clinical Research Centre, Bellville, Cape Town, South Africa.
  • Swindells S; College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska.
  • Bishai W; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Lancet Microbe ; 1(2): e84-e92, 2020 06.
Article en En | MEDLINE | ID: mdl-33834177

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Isoniazida / Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Lancet Microbe Año: 2020 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Isoniazida / Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Lancet Microbe Año: 2020 Tipo del documento: Article País de afiliación: Sudáfrica